60 related articles for article (PubMed ID: 18755815)
41. Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death.
Yang MC; Lung FW
Psychopharmacology (Berl); 2011 Oct; 217(3):397-410. PubMed ID: 21523348
[TBL] [Abstract][Full Text] [Related]
42. Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells.
Schmidt AJ; Krieg JC; Clement HW; Gebhardt S; Schulz E; Heiser P
J Psychopharmacol; 2010 Dec; 24(12):1829-33. PubMed ID: 19605603
[TBL] [Abstract][Full Text] [Related]
43. The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro.
Melkersson K; Jansson E
Neuro Endocrinol Lett; 2005 Jun; 26(3):205-8. PubMed ID: 15990722
[TBL] [Abstract][Full Text] [Related]
44. Haloperidol and atypical antipsychotics share a same action of decreasing P75(NTR) mRNA levels in PC12 cells.
Bai O; Xu H; Li XM
Life Sci; 2006 Jul; 79(6):570-4. PubMed ID: 16513140
[TBL] [Abstract][Full Text] [Related]
45. Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.
Celikyurt IK; Kayir H; Ulak G; Erden FB; Ulusoy GK; Uzbay TI
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):528-36. PubMed ID: 21168466
[TBL] [Abstract][Full Text] [Related]
46. Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro.
Heiser P; Enning F; Krieg JC; Vedder H
J Psychopharmacol; 2007 Nov; 21(8):851-6. PubMed ID: 17881431
[TBL] [Abstract][Full Text] [Related]
47. Clinical relevance of relative receptor binding affinity: quetiapine and ziprasidone as examples.
Preskorn SH
J Psychiatr Pract; 2007 Nov; 13(6):393-8. PubMed ID: 18032984
[No Abstract] [Full Text] [Related]
48. Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro.
Schmidt AJ; Krieg JC; Clement HW; Hemmeter UM; Schulz E; Vedder H; Heiser P
J Psychopharmacol; 2010 Mar; 24(3):349-54. PubMed ID: 18755815
[TBL] [Abstract][Full Text] [Related]
49. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
50. Using oral ziprasidone effectively: the food effect and dose-response.
Citrome L
Adv Ther; 2009 Aug; 26(8):739-48. PubMed ID: 19669631
[TBL] [Abstract][Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]